IDE targets Amyloid beta
Evidence from:
primary |
all sources
Evidence (1 sources)
New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy.
(2014)
PMID:25368578
cited
IDE is also known to have Aβ-degrading properties
confidence: 0.95